Skip to search
Skip to main content
Catalog
Help
Feedback
Your Account
Library Account
Bookmarks
(
0
)
Search History
Search in
Keyword
Title (keyword)
Author (keyword)
Subject (keyword)
Title starts with
Subject (browse)
Author (browse)
Author (sorted by title)
Call number (browse)
search for
Search
Advanced Search
Bookmarks
(
0
)
Princeton University Library Catalog
Start over
Cite
Send
to
SMS
Email
EndNote
RefWorks
RIS
Printer
Bookmark
Health Advocacy, Inc. : how pharmaceutical funding changed the breast cancer movement / Sharon Batt.
Author
Batt, Sharon, 1945-
[Browse]
Format
Book
Language
English
Published/Created
Vancouver : UBC Press, [2017]
Description
xii, 383 pages : illustrations
Availability
Copies in the Library
Location
Call Number
Status
Location Service
Notes
Firestone Library - Stacks
R727.45 .B38 2017
Browse related items
Request
Details
Subject(s)
Patient advocacy
—
Canada
[Browse]
Breast
—
Cancer
—
Research
—
Canada
—
Finance
[Browse]
Pharmaceutical industry
—
Canada
[Browse]
Medical policy
—
Canada
[Browse]
Medical policy
[Browse]
Summary note
"Today, most patient groups in Canada are funded by the pharmaceutical industry, raising an important ethical question: Do alliances between patient organizations and corporate sponsors ultimately lead to policies that are counter to the public interest? In this examination of Canada's breast cancer movement from 1990 to 2010, health activist, scholar, and cancer survivor Sharon Batt investigates the relationship between patient advocacy groups and the pharmaceutical industry--and the hidden implications of pharma funding for health policy. Health Advocacy, Inc. dissects the alliances between the companies that sell pharmaceuticals and the individuals who use them, drawing links between neoliberalism and corporate financing, and the ensuing threat to the public health care system. Batt combines archival analysis, interviews with advocacy and industry representatives, and personal observation to reveal how a reduction in state funding drove patient groups to form partnerships with the private sector. The resulting power imbalance continues to challenge the groups' ability to put patients' interests ahead of those of the industry. Batt's conclusion is unsettling: a once-vibrant movement that encouraged democratic participation in the development of health policy now eerily echoes the demands of the pharmaceutical industry. This thorough account of the shift from grassroots advocacy to Big Pharma partnership defines the struggles and stakes of activism in public health today."-- Provided by publisher.
Bibliographic references
Includes bibliographical references (pages 296-350) and index.
Contents
Canada's health policy landscape
Health advocacy organizations in Canada
Beginnings of the breast cancer movement
Advocacy redefined
The movement fractures over pharma funding
Pharma funding as the new norm
Advocacy groups and the continuing struggle over the pharma-funding question.
Show 4 more Contents items
ISBN
9780774833844 ((alk. paper))
077483384X ((alk. paper))
LCCN
2017302029
OCLC
992742628
Statement on language in description
Princeton University Library aims to describe library materials in a manner that is respectful to the individuals and communities who create, use, and are represented in the collections we manage.
Read more...
Other views
Staff view
Ask a Question
Suggest a Correction
Report Harmful Language
Supplementary Information